Skip to main content
. 2020 Nov 2;8:e10288. doi: 10.7717/peerj.10288

Table 4. Comparing the antibacterial activity of Bacillus sp. and purified amylase enzyme to different standard antibiotics.

Tested pathogens/Antibiotica/Isolates Escherichia coli Klebsiella pneumoniae Acinetobacter baumanii Pseudomonas aeuroginosa Staphylococcus aureus (MRSA)
Chloramphenicol (30 µg) S R S I I
Oxacillin (1 mcg) NA NA NA NA R
Vancomycin (30 mcg) NA NA NA NA R
Ampicillin- sulbactam (10/10 mcg) I I R I NA
Pencillin G (10 U) NA NA NA NA R
Erythromycin (15 mcg) NA NA NA NA I
Sulfameth.-trimethoprim (23.75/1.25 µg) R R R R I
Cefotaxime (30 mcg) R R R R R
Gentamycin (10 µg) R R R R R
Meropenem (10 µg) S R R R NA
Piperacillin (100 µg) R R R R NA
Piperacillin-tazobactam (100/10 µg) R R R S NA

Notes.

a

Comparing the antimicrobial susceptibility of a group of standard antibiotics (CLSI, 2017) against five human pathogenic strains (control).

b

Antimicrobial activity of the isolated Bacillus sp.

R
Resistant
S
sensitive
I
intermediate
NA
Not applicable (for antibiotics that were not specific to the bacterial strains)
NI
No inhibition
C
antimicrobial activity of purified amylase from some isolated Bacillus sp.
ABM
amylase purified from Bacillus megaterium
ABS
amylase purified from Bacillus subtilis
ABC
amylase purified from purified Bacillus cereus
ABT
amylase purified from Bacillus thuringiesis
ABL
amylase purified from Bacillus lentus
ABA
amylase purified from Bacillus alvei

Values expressed as mean ± SD.